rs80356743

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP2PP3

The NM_007375.4(TARDBP):​c.1178C>T​(p.Ser393Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000695 in 1,439,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S393S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

TARDBP
NM_007375.4 missense

Scores

5
6
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.18

Publications

36 publications found
Variant links:
Genes affected
TARDBP (HGNC:11571): (TAR DNA binding protein) HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene is a transcriptional repressor that binds to chromosomally integrated TAR DNA and represses HIV-1 transcription. In addition, this protein regulates alternate splicing of the CFTR gene. A similar pseudogene is present on chromosome 20. [provided by RefSeq, Jul 2008]
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
MASP2 Gene-Disease associations (from GenCC):
  • immunodeficiency due to MASP-2 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the TARDBP gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 22 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 3.7095 (above the threshold of 3.09). Trascript score misZ: 5.3115 (above the threshold of 3.09). GenCC associations: The gene is linked to amyotrophic lateral sclerosis type 10, frontotemporal dementia with motor neuron disease, amyotrophic lateral sclerosis, inclusion body myositis.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.805

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TARDBPNM_007375.4 linkc.1178C>T p.Ser393Leu missense_variant Exon 6 of 6 ENST00000240185.8 NP_031401.1 Q13148-1Q9H256A0A024R4E2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TARDBPENST00000240185.8 linkc.1178C>T p.Ser393Leu missense_variant Exon 6 of 6 1 NM_007375.4 ENSP00000240185.4 Q13148-1
TARDBPENST00000649624.1 linkc.768+410C>T intron_variant Intron 5 of 5 ENSP00000497327.1 A0A0A0N0M3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000867
AC:
2
AN:
230568
AF XY:
0.00000807
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000487
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.95e-7
AC:
1
AN:
1439392
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
713750
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32664
American (AMR)
AF:
0.00
AC:
0
AN:
41212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24740
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39468
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82690
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52748
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5630
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1100842
Other (OTH)
AF:
0.00
AC:
0
AN:
59398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 10;C3150169:FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED Uncertain:1
Apr 26, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 19224587, 19714537, 21830990, 29630989). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 393 of the TARDBP protein (p.Ser393Leu). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Pathogenic
0.49
D
BayesDel_noAF
Pathogenic
0.46
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
T;T;.
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.81
.;T;T
M_CAP
Benign
0.081
D
MetaRNN
Pathogenic
0.80
D;D;D
MetaSVM
Uncertain
0.69
D
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
7.2
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.2
N;.;.
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0090
D;.;.
Sift4G
Benign
0.24
T;.;.
Polyphen
0.80
P;P;.
Vest4
0.89
MutPred
0.72
Loss of glycosylation at S393 (P = 0.0011);Loss of glycosylation at S393 (P = 0.0011);.;
MVP
0.99
MPC
0.82
ClinPred
0.37
T
GERP RS
5.3
PromoterAI
0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.22
gMVP
0.75
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80356743; hg19: chr1-11082644; COSMIC: COSV53569659; COSMIC: COSV53569659; API